SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

PAPI, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 48.445
AS - Asia 25.630
EU - Europa 14.097
SA - Sud America 4.319
Continente sconosciuto - Info sul continente non disponibili 1.370
AF - Africa 634
OC - Oceania 199
Totale 94.694
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 47.136
SG - Singapore 9.253
CN - Cina 5.337
IT - Italia 3.713
BR - Brasile 3.289
VN - Vietnam 2.709
HK - Hong Kong 2.403
DE - Germania 1.895
UA - Ucraina 1.889
BD - Bangladesh 1.591
FI - Finlandia 1.325
GB - Regno Unito 1.298
TR - Turchia 1.185
FR - Francia 863
NL - Olanda 763
JP - Giappone 741
RU - Federazione Russa 646
CA - Canada 627
SE - Svezia 575
IN - India 564
ID - Indonesia 531
MX - Messico 410
AR - Argentina 375
PL - Polonia 308
IQ - Iraq 195
ZA - Sudafrica 184
AU - Australia 177
EC - Ecuador 161
ES - Italia 158
PK - Pakistan 157
CO - Colombia 135
AT - Austria 122
PH - Filippine 117
MY - Malesia 102
MA - Marocco 94
VE - Venezuela 92
SA - Arabia Saudita 91
PY - Paraguay 84
KR - Corea 83
BE - Belgio 79
UZ - Uzbekistan 76
LT - Lituania 72
EG - Egitto 71
AE - Emirati Arabi Uniti 69
CL - Cile 69
TN - Tunisia 67
TW - Taiwan 66
KE - Kenya 60
PE - Perù 54
JM - Giamaica 53
CZ - Repubblica Ceca 51
TH - Thailandia 44
CH - Svizzera 42
CR - Costa Rica 42
DZ - Algeria 41
IE - Irlanda 41
GT - Guatemala 32
UY - Uruguay 32
JO - Giordania 30
NP - Nepal 30
KZ - Kazakistan 29
PT - Portogallo 28
LB - Libano 26
RO - Romania 26
AL - Albania 25
AZ - Azerbaigian 24
GR - Grecia 24
IL - Israele 24
BO - Bolivia 22
IR - Iran 21
HN - Honduras 20
NZ - Nuova Zelanda 20
ET - Etiopia 19
PS - Palestinian Territory 18
RS - Serbia 18
SV - El Salvador 18
BG - Bulgaria 17
HR - Croazia 17
DO - Repubblica Dominicana 16
TT - Trinidad e Tobago 16
MK - Macedonia 15
NI - Nicaragua 15
EU - Europa 13
GE - Georgia 13
HU - Ungheria 13
NG - Nigeria 12
PA - Panama 12
BH - Bahrain 11
OM - Oman 11
DK - Danimarca 10
SN - Senegal 10
SY - Repubblica araba siriana 10
BB - Barbados 9
MD - Moldavia 9
SI - Slovenia 9
XK - ???statistics.table.value.countryCode.XK??? 9
BY - Bielorussia 8
KH - Cambogia 8
KW - Kuwait 8
LK - Sri Lanka 8
Totale 93.140
Salva come PNG Salva come JPEG
Città #
Singapore 5.664
Ashburn 5.595
Fairfield 4.048
Woodbridge 3.631
Houston 2.669
San Jose 2.635
Hong Kong 2.355
Jacksonville 2.051
Santa Clara 1.877
Chandler 1.631
Dallas 1.578
Seattle 1.560
Wilmington 1.437
Council Bluffs 1.383
Beijing 1.371
Ann Arbor 1.327
Cambridge 1.319
Los Angeles 956
New York 943
Ho Chi Minh City 893
Helsinki 732
Izmir 702
Tokyo 697
Nanjing 639
Hanoi 631
Princeton 566
Lauterbourg 549
Milan 549
Munich 520
San Diego 379
Jakarta 374
Ferrara 348
Boardman 318
Chicago 307
São Paulo 279
Warsaw 271
Washington 264
Rome 256
Mexico City 255
Buffalo 244
Toronto 226
Shanghai 219
Orem 202
London 198
Nanchang 197
Tianjin 178
Shenyang 173
Denver 158
Atlanta 155
Hefei 155
San Francisco 154
Montreal 149
Moscow 143
Frankfurt am Main 142
Addison 131
Da Nang 130
Hebei 124
Phoenix 122
Brooklyn 119
Changsha 116
Lappeenranta 116
Dearborn 111
Nuremberg 108
Rio de Janeiro 104
Haiphong 103
Jiaxing 102
Naples 102
Bologna 101
Boston 100
Turku 93
Chennai 92
Dong Ket 90
Mountain View 87
Guangzhou 84
The Dalles 84
Stockholm 83
Falls Church 80
Baghdad 78
Falkenstein 76
Redwood City 74
Zhengzhou 70
Norwalk 69
Belo Horizonte 66
Tashkent 66
Johannesburg 65
Manchester 65
Amsterdam 62
Curitiba 61
Vienna 61
Mumbai 59
Quito 59
Sydney 59
Dhaka 56
Kuala Lumpur 56
Turin 55
Jinan 54
Columbus 53
Kunming 53
Verona 53
Biên Hòa 50
Totale 60.054
Salva come PNG Salva come JPEG
Nome #
Intravenous N-acetylcysteine in respiratory disease with abnormal mucus secretion 1.002
Pharmacokinetics and Safety of Single and Multiple Doses of Oral N-Acetylcysteine in Healthy Chinese and Caucasian Volunteers: An Open-Label, Phase I Clinical Study 926
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program 681
Safety of N-Acetylcysteine at High Doses in Chronic Respiratory Diseases: A Review 617
Air pollution and COPD: GOLD 2023 committee report 551
Asthma death. Part 1: Clinical phenotypes, epidemiology and risk factors 534
Asthma 524
From Gold 0 to Pre-COPD 455
Value of fiberoptic bronchoscopy in addition to 18F-FDG-PET/CT in the differentiation of solitary pulmonary nodules: a prospective study 445
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial 400
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 348
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 348
N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses 346
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial 335
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 330
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 317
Targeting Th2 cells in asthmatic airways 306
Blood Eosinophils and Chronic Obstructive Pulmonary Disease: A GOLD Science Committee 2022 Review 300
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial 298
Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS) 290
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 289
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial 279
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 277
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD 271
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 271
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 266
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 265
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 255
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 254
Primary pulmonary epithelioid hemangioendothelioma: A rare cause of PET-negative pulmonary nodules 251
Oxygen radical scavengers inhibit clastogenic activity induced by sonication of human serum 246
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial 246
Emphysema contribution to the progression of chronic obstructive pulmonary disease. 245
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 243
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 239
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma 237
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 232
Bronchopulmonary inflammation and airway smooth muscle hyperresponsiveness induced by nitrogen dioxide in guinea pigs 230
An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal 227
Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma 225
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients 225
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 224
Respiratory Syncytial Virus Infection in Older Adults: An Update 223
Severe Pneumonia following intravescical BCG therapy in a patient with bladder cancer. 222
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial 222
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 222
A serum proteome signature to predict mortality in severe COVID-19 patients 222
Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial 221
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 220
Reducing agents decrease the oxidative burst and improve clinical outcomes in COPD patients: A randomised controlled trial on the effects of sulphurous thermal water inhalation 220
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 219
Description of a randomised controlled trial of inhaled corticosteroid/fast-onset LABA reliever therapy in mild asthma 219
Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease 219
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline 219
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease 217
Extrafine Versus Fine Inhaled Corticosteroids in Relation to Asthma Control: A Systematic Review and Meta-Analysis of Observational Real-Life Studies 217
Effect of subchronic in vivo exposure to nitrogen dioxide on lung tissue inflammation, airway microvascular leakage, and in vitro bronchial muscle responsiveness in rats 216
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 216
Activation of NF-kappaB transcription factor in asthma death 216
Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients 216
Diffuse pulmonary meningothelial like nodules simulating metastatic thymoma 215
Malattie polmonari primitive da cause dismetaboliche. 214
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 214
Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy 213
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 213
Cellule staminali e patologia polmonare dell’adulto 212
A new combination therapy for asthma: bridging the gap between effectiveness in trials and clinical practice? 211
Efficacy of fluticasone propionate/formoterol fumarate in the treatment of asthma: A pooled analysis 211
A randomized, double-blinded, double-dummy efficacy and safety study of budesonide-formoterol Spiromax® compared to budesonide-formoterol Turbuhaler® in adults and adolescents with persistent asthma 211
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients 210
Natural Killer Cells in SARS-CoV-2-Vaccinated Subjects with Increased Effector Cytotoxic CD56dim Cells and Memory-Like CD57+NKG2C+CD56dim Cells 209
Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium 208
Asthma management 207
COPD: early diagnosis and treatment to slow disease progression 206
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 205
A defective type 1 response to rhinovirus in atopic asthma 204
Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes 204
Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations 203
A Novel Insight into Adaptive Immunity in Chronic Obstructive Pulmonary Disease B Cell Activating Factor Belonging to the Tumor Necrosis Factor Family 203
Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells 202
Interleukin-13 and-4 expression in the central airways of smokers with chronic bronchitis 202
Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells 202
Enfisema polmonare: prospettive di terapia 201
A valid option for asthma control: Clinical evidence on efficacy and safety of fluticasone propionate/formoterol combination in a single inhaler 200
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 199
Circulating endothelial stem cells are not decreased in pulmonary emphysema or COPD 199
Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease 198
Apporto esogeno di riducenti e attività del rinovirus HRV16 197
Achieving the balance between evidence and simplicity 197
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 197
Rhinovirus vaccination: the case against 196
Rhinovirus Infection Induces Degradation of Antimicrobial Peptides and Secondary Bacterial Infection in Chronic Obstructive Pulmonary Disease 194
Dual Bronchodilation Response by Exacerbation History and Eosinophilia in the FLAME Study 194
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 194
Ectopic thymoma simulating a pericardial cyst: case report 194
Models of infection and exacerbations in COPD. 191
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics 191
COPD exacerbations: definitions and classifications 191
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study 191
Mechanisms of rhinovirus-induced asthma 191
Totale 26.890
Salva come PNG Salva come JPEG
Categoria #
all - tutte 430.562
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 19.276
Totale 449.838
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.927 0 452 320 258 197 236 283 293 204 380 461 1.843
2022/20234.213 575 103 145 491 619 645 179 385 531 65 314 161
2023/20242.742 248 267 113 83 137 279 78 136 88 259 348 706
2024/202511.287 303 293 998 331 1.307 813 351 716 1.934 1.653 1.447 1.141
2025/202638.479 2.708 1.677 3.921 4.392 4.676 2.199 4.067 2.238 3.792 4.235 2.590 1.984
2026/20276.137 3.029 3.108 0 0 0 0 0 0 0 0 0 0
Totale 94.694